|
1
|
van der Poll T and Opal SM: Host-pathogen
interactions in sepsis. Lancet Infect Dis. 8:32–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bagshaw SM, George C and Bellomo R; ANZICS
Database Management Committee, : Early acute kidney injury and
sepsis: A multicentre evaluation. Crit Care. 12:R472008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kissoon N, Daniels R, van der Poll T,
Finfer S and Reinhart K: Sepsis-the final common pathway to death
from multiple organ failure in infection. Crit Care Med.
44:e4462016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shum HP, Yan WW and Chan TM: Recent
knowledge on the pathophysiology of septic acute kidney injury: A
narrative review. J Crit Care. 31:82–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McCormack D and McFadden D: A review of
pterostilbene antioxidant activity and disease modification. Oxid
Med Cell Longev. 2013:5754822013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kapetanovic IM, Muzzio M, Huang Z,
Thompson TN and McCormick DL: Pharmacokinetics, oral
bioavailability, and metabolic profile of resveratrol and its
dimethylether analog, pterostilbene, in rats. Cancer Chemother
Pharmacol. 68:593–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smeding L, Leong-Poi H, Hu P, Shan Y,
Haitsma JJ, Horvath E, Furmli S, Masoom H, Kuiper JW, Slutsky AS,
et al: Salutary effect of resveratrol on sepsis-induced myocardial
depression. Crit Care Med. 40:1896–1907. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holthoff JH, Wang Z, Seely KA, Gokden N
and Mayeux PR: Resveratrol improves renal microcirculation,
protects the tubular epithelium, and prolongs survival in a mouse
model of sepsis-induced acute kidney injury. Kidney Int.
81:370–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sebai H, Ben-Attia M, Sani M, Aouani E and
Ghanem-Boughanmi N: Protective effect of resveratrol in
endotoxemia-induced acute phase response in rats. Arch Toxicol.
83:335–340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Yang S, Zumbrun EE, Guan H,
Nagarkatti PS and Nagarkatti M: Resveratrol attenuates
lipopolysaccharide-induced acute kidney injury by suppressing
inflammation driven by macrophages. Mol Nutr Food Res. 59:853–864.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LW, Chen W, Hu ZQ, Bian JL, Ying L,
Hong GL, Qiu QM, Zhao GJ and Lu ZQ: Protective effects of growth
arrest-specific protein 6 (Gas6) on sepsis-induced acute kidney
injury. Inflammation. 39:575–582. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doi K, Leelahavanichkul A, Yuen PS and
Star RA: Animal models of sepsis and sepsis-induced kidney injury.
J Clin Invest. 119:2868–2878. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Umbro I, Gentile G, Tinti F, Muiesan P and
Mitterhofer AP: Recent advances in pathophysiology and biomarkers
of sepsis-induced acute kidney injury. J Infect. 72:131–142. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hutchins NA, Unsinger J, Hotchkiss RS and
Ayala A: The new normal: Immunomodulatory agents against sepsis
immune suppression. Trends Mol Med. 20:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pettilä V and Bellomo R: Understanding
acute kidney injury in sepsis. Intensive Care Med. 40:1018–1020.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiler H and Ruf W: Activated protein C in
sepsis: The promise of nonanticoagulant activated protein C. Curr
Opin Hematol. 15:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X, Yang X, Han L, Ye F, Liu M, Fan W,
Zhang K, Kong Y, Zhang J, Shi L, et al: Pterostilbene alleviates
polymicrobial sepsis-induced liver injury: Possible role of SIRT1
signaling. Int Immunopharmacol. 49:50–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gómez H and Kellum JA: Sepsis-induced
acute kidney injury. Curr Opin Crit Care. 22:546–553. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Zhao L, Yue L, Wang B, Li X, Guo H,
Ma Y, Yao C, Gao L, Deng J, et al: Pterostilbene attenuates early
brain injury following subarachnoid hemorrhage via inhibition of
the NLRP3 inflammasome and Nox2-related oxidative stress. Mol
Neurobiol. Sep 24–2016.(Epub ahead of print).
|
|
21
|
Jemmerson R, Dubinsky JM and Brustovetsky
N: Cytochrome C release from CNS mitochondria and potential for
clinical intervention in apoptosis-mediated CNS diseases. Antioxid
Redox Signal. 7:1158–1172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luna-Vargas MP and Chipuk JE:
Physiological and pharmacological control of BAK, BAX, and beyond.
Trends Cell Biol. 26:906–917. 2016. View Article : Google Scholar : PubMed/NCBI
|
